Methodology for identifying patients at high risk for osteoporotic fracture

Clinical Therapeutics

Volumn 23, Issue 9, 2001, Pages 1570-1588

  Westfall, Gina ^a   Littlefield, Russell ^a   Heaton, Alan ^a   Martin, Steven ^a  

^a Prime Therapeutics   (United States)

Author keywords

Claims database; Fracture; Osteoporosis; Predictive; Risk model

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETAMETHASONE; CORTISONE ACETATE; DEXAMETHASONE; FLUNISOLIDE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ADULT; AGE; AGED; ALCOHOLISM; ARTICLE; BONE DENSITY; CIGARETTE SMOKING; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MATHEMATICAL MODEL; METHODOLOGY; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PATIENT SELECTION; PREDICTION; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STEROID THERAPY; VALIDATION PROCESS;

EID: 0034801401     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80129-6     Document Type: Article

References (11)

1. How many women have osteoporosis now?
2. Declining bone mass in men with chronic pulmonary disease: Contributions of glucocorticoid treatment, body mass index, and gonadal function
3. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation
4. Costs and health effects of osteoporotic fractures
5. Osteoporosis: Current modes of prevention and treatment
6. Inhaled corticosteroid use and bone-mineral density in patients with asthma
7. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis
8. Inhaled and oral corticosteroids: Their effects on bone mineral density in older adults